関連する実験動画
Updated: Aug 1, 2026

09:40
Functional Cloning Using a Xenopus Oocyte Expression System
Published on: January 30, 2016
まとめ
エストラディオール-17βは,Xenopus tadpoleの肝臓のタンパク質合成を大幅に増加させます. 変形後,このホルモンは特に肝臓組織でビテロゲニンの産生を誘発する.
科学分野:
- エンドクリノロジー エンドクリノロジー
- 発達生物学 発達生物学とは
- 分子生物学は分子生物学である.
背景:
- エストラディオール-17βは,様々な生理学的プロセスを調節する重要なホルモンです.
- クセノプス・タドポールの肝臓組織は,変形過程で大きな変化を経験します.
- エストロゲンシグナル伝達は,両生類の発達と代謝において重要な役割を果たします.
研究 の 目的:
- エストラディオール17βがXenopus tadpoleの肝臓のタンパク質合成に及ぼす影響を調査する.
- エストロゲン誘発のタンパク質生産,特にビテロゲニンの発達のタイミングを決定する.
- エストラディオール17βが,変異後の肝臓で分泌されるタンパク質に及ぼす作用の特異性を分析する.
主な方法:
- 異なった発達段階 (第50段階以降から第66段階まで) にあるXenopus tadpoleの肝臓組織の一次培養.
- タンパク質合成を刺激するエストラジオール-17βによる治療.
- 培養媒体の分泌タンパク質の分析は,放射性標識と電泳などの技術を用いて行われます.
主要な成果:
- エストラディオール-17βは,変異の第50段階から第50段階までのXenopus tadpoleの肝臓で分泌される複数のタンパク質の合成を刺激します.
- エストロゲン誘発のビテロゲニンは,第54段階から検出されるが,変形が完了するまでマイナーな成分である.
- 変異後の肝臓では,エストラジオール-17βは,他の分泌されるタンパク質に影響を及ぼすことなく,特にビテロゲニンの合成を強化します.
結論:
- エストラディオール17βの肝臓タンパク質合成への影響は,Xenopusの変形過程で進化する.
- ビテロゲニンの生成は,変形後,肝臓におけるエストロゲン反応性分泌経路が優勢となる.
- これは,成人の肝臓における黄蛋白前駆体合成の調節におけるエストラディオール-17βの特定の役割を強調しています.
関連する概念動画
Drug Metabolism: Phase I Reactions
A phase I reaction is a biochemical process that introduces a functionally reactive polar group to a substance. This transformation predominantly occurs in the liver, facilitated by the cytochrome P450 system of hemoproteins situated in the lipophilic endoplasmic reticulum of cells. The metabolite generated through this process can have varying polarities. If it is sufficiently polar, it can be easily excreted in the urine due to its water compatibility. However, if the metabolite is nonpolar,...
Phase I Oxidative Reactions: Overview
Phase I biotransformation, or functionalization, is a crucial chemical process that converts drugs and other xenobiotics into more water-soluble forms, facilitating expulsion from the body. It involves oxidative, reductive, and hydrolytic reactions that add or unveil polar functional groups on lipophilic substrates. Key players in phase I reactions are the mixed-function oxidases. Situated in liver cell microsomes, these enzymes predominantly carry out drug metabolism. They require molecular...
Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems
Phase I biotransformation reactions are integral to drug metabolism, predominantly involving oxidative, reductive, and hydrolytic transformations. Chief among these are oxidative reactions, which enhance the hydrophilicity of xenobiotics and introduce polar functional groups to facilitate their elimination from the body.
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
Phase I Reactions: Reductive Reactions
Phase I biotransformation reductive reactions are chemical processes that modify drugs by introducing or revealing polar functional groups via reduction. Enzymes called reductases catalyze these reactions, playing a pivotal role in drug metabolism by transforming lipophilic drugs into more polar, water-soluble metabolites for easy excretion. An essential type of reductive reaction is the carbonyl group reduction, where aldehydes and ketones are reduced to alcohols. An example is the...
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation
Glutathione, a tripeptide made up of glutamate, cysteine, and glycine, is a critical player in the detoxification of drugs and xenobiotics via a process known as glutathione conjugation or mercapturic acid formation. This phase II biotransformation reaction involves the covalent binding of glutathione to a drug or its metabolite, enhancing the compound's water solubility and enabling its excretion.
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Bioactivation and Tissue Toxicity
Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...

